0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home
Back Home

Faith Osier


29 results

Genetic diversity and natural selection of Plasmodium falciparum Pf41 vaccine candidate in clinical isolates from Senegal.Sane, R. Sambe, B. S. Diagne, A. Faye, J. Sarr, F. D. Diaw, S. O. M. Sarr, I. Diatta, A. S. Diatta, H. A. M. Sembene, P. M. Vigan-Womas, I. Toure-Balde, A. Osier, F. Niang, M.
Sci Rep, (2025). 15:16516

A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.Ogwang, R. Osoti, V. Wamae, K. Ndwiga, L. Muteru, K. Ningwa, A. Tuju, J. Kinyanjui, S. Osier, F. Marsh, K. Bejon, P. Idro, R. Ochola-Oyier, L. I.
Antimicrob Agents Chemother, (2024). 68:e0157623

The effect of malaria on childhood anemia in a quasi-experimental study of 7,384 twins from 23 Sub-Saharan African countries.Starck, T. Dambach, P. Rouamba, T. Tinto, H. Osier, F. Oldenburg, C. E. Adam, M. Barnighausen, T. Jaenisch, T. Bulstra, C. A.
Front Public Health, (2022). 10:1009865

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.Fernandez, N. Hayes, P. Makinde, J. Hare, J. King, D. Xu, R. Rehawi, O. Mezzell, A. T. Kato, L. Mugaba, S. Serwanga, J. Chemweno, J. Nduati, E. Price, M. A. Osier, F. Ochsenbauer, C. Yue, L. Hunter, E. Gilmour, J. Iavi protocol C investigators
Front Immunol, (2022). 13:1029029

Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.Mwai, K. Nkumama, I. Thairu, A. Mburu, J. Odera, D. Kimathi, R. Nyamako, L. Tuju, J. Kinyanjui, S. Musenge, E. Osier, F.
Malar J, (2022). 21:326

Asplenia and spleen hypofunction.Lenti, M. V. Luu, S. Carsetti, R. Osier, F. Ogwang, R. Nnodu, O. E. Wiedermann, U. Spencer, J. Locatelli, F. Corazza, G. R. Di Sabatino, A.
Nat Rev Dis Primers, (2022). 8:71

Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact.Oseno, B. Marura, F. Ogwang, R. Muturi, M. Njunge, J. Nkumama, I. Mwakesi, R. Mwai, K. Rono, M. K. Mwakubambanya, R. Osier, F. Tuju, J.
Parasit Vectors, (2022). 15:11

Determinants of the varied profiles of Plasmodium falciparum infections among infants living in Kintampo, Ghana.Botwe, A. K. Oppong, F. B. Gyaase, S. Owusu-Agyei, S. Asghar, M. Asante, K. P. Farnert, A. Osier, F.
Malar J, (2021). 20:240

protGear: A protein microarray data pre-processing suite.Mwai, K. Kibinge, N. Tuju, J. Kamuyu, G. Kimathi, R. Mburu, J. Chepsat, E. Nyamako, L. Chege, T. Nkumama, I. Kinyanjui, S. Musenge, E. Osier, F.
Comput Struct Biotechnol J, (2021). 19:2518-2525

Correction: Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana.Botwe, A. K. Owusu-Agyei, S. Asghar, M. Hammar, U. Oppong, F. B. Gyaase, S. Dosoo, D. Jakpa, G. Boamah, E. Twumasi, M. F. Osier, F. Farnert, A. Asante, K. P.
PLoS One, (2021). 16:e0246773

Profiles of Plasmodium falciparum infections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana.Botwe, A. K. Owusu-Agyei, S. Asghar, M. Hammar, U. Oppong, F. B. Gyaase, S. Dosoo, D. Jakpa, G. Boamah, E. Twumasi, M. F. Osier, F. Farnert, A. Asante, K. P.
PLoS One, (2020). 15:e0240814

The global response to the COVID-19 pandemic: how have immunology societies contributed?.Osier, F. Ting, J. P. Y. Fraser, J. Lambrecht, B. N. Romano, M. Gazzinelli, R. T. Bortoluci, K. R. Zamboni, D. S. Akbar, A. N. Evans, J. Brown, D. E. Patel, K. D. Wu, Y. Perez, A. B. Perez, O. Kamradt, T. Falk, C. Barda-Saad, M. Ariel, A. Santoni, A. Annunziato, F. Cassatella, M. A. Kiyono, H. Chereshnev, V. Dieye, A. Mbow, M. Mbengue, B. Niang, M. D. S. Suchard, M.
Nat Rev Immunol, (2020). 20:594-602

Editorial: Regulation of Immunity to Parasitic Infections Endemic to Africa.Osier, F. Uzonna, J. E.
Front Immunol, (2020). 11:1159

Toward personalization of asthma treatment according to trigger factors.Niespodziana, K. Borochova, K. Pazderova, P. Schlederer, T. Astafyeva, N. Baranovskaya, T. Barbouche, M. R. Beltyukov, E. Berger, A. Borzova, E. Bousquet, J. Bumbacea, R. S. Bychkovskaya, S. Caraballo, L. Chung, K. F. Custovic, A. Docena, G. Eiwegger, T. Evsegneeva, I. Emelyanov, A. Errhalt, P. Fassakhov, R. Fayzullina, R. Fedenko, E. Fomina, D. Gao, Z. Giavina-Bianchi, P. Gotua, M. Greber-Platzer, S. Hedlin, G. Ilina, N. Ispayeva, Z. Idzko, M. Johnston, S. L. Kalayci, O. Karaulov, A. Karsonova, A. Khaitov, M. Kovzel, E. Kowalski, M. L. Kudlay, D. Levin, M. Makarova, S. Matricardi, P. M. Nadeau, K. C. Namazova-Baranova, L. Naumova, O. Nazarenko, O. O'Byrne, P. M. Osier, F. Pampura, A. N. Panaitescu, C. Papadopoulos, N. G. Park, H. S. Pawankar, R. Pohl, W. Renz, H. Riabova, K. Sampath, V. Sekerel, B. E. Sibanda, E. Siroux, V. Sizyakina, L. P. Sun, J. L. Szepfalusi, Z. Umanets, T. Van Bever, H. P. S. van Hage, M. Vasileva, M. von Mutius, E. Wang, J. Y. Wong, G. W. K. Zaikov, S. Zidarn, M. Valenta, R.
J Allergy Clin Immunol, (2020). 145:1529-1534

Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya.Njuguna, P. Maitland, K. Nyaguara, A. Mwanga, D. Mogeni, P. Mturi, N. Mohammed, S. Mwambingu, G. Ngetsa, C. Awuondo, K. Lowe, B. Adetifa, I. Scott, J. A. G. Williams, T. N. Atkinson, S. Osier, F. Snow, R. W. Marsh, K. Tsofa, B. Peshu, N. Hamaluba, M. Berkley, J. A. Newton, C. R. J. Fondo, J. Omar, A. Bejon, P.
BMC Med, (2019). 17:124

Transmission and Age Impact the Risk of Developing Febrile Malaria in Children with Asymptomatic Plasmodium falciparum Parasitemia.Wamae, K. Wambua, J. Nyangweso, G. Mwambingu, G. Osier, F. Ndung'u, F. Bejon, P. Ochola-Oyier, L. I.
J Infect Dis, (2019). 219:936-944

The 2015-2016 malaria epidemic in Northern Uganda; What are the implications for malaria control interventions?.Ogwang, R. Akena, G. Yeka, A. Osier, F. Idro, R.
Acta Trop, (2018). 188:27-33

Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.Feng, G. Boyle, M. J. Cross, N. Chan, J. A. Reiling, L. Osier, F. Stanisic, D. I. Mueller, I. Anders, R. F. McCarthy, J. S. Richards, J. S. Beeson, J. G.
J Infect Dis, (2018). 218:35-43

Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure.Abdi, A. I. Hodgson, S. H. Muthui, M. K. Kivisi, C. A. Kamuyu, G. Kimani, D. Hoffman, S. L. Juma, E. Ogutu, B. Draper, S. J. Osier, F. Bejon, P. Marsh, K. Bull, P. C.
BMC Infect Dis, (2017). 17:585

High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical Malaria.Offeddu, V. Olotu, A. Osier, F. Marsh, K. Matuschewski, K. Thathy, V.
Front Immunol, (2017). 8:488